145 related articles for article (PubMed ID: 15000871)
1. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
3. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
[TBL] [Abstract][Full Text] [Related]
4. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
[TBL] [Abstract][Full Text] [Related]
5. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
6. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
7. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
Ma Y; Thomas MG; Okamoto M; Bogdanos DP; Nagl S; Kerkar N; Lopes AR; Muratori L; Lenzi M; Bianchi FB; Mieli-Vergani G; Vergani D
J Immunol; 2002 Jul; 169(1):277-85. PubMed ID: 12077255
[TBL] [Abstract][Full Text] [Related]
8. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to thyroid disorders in hepatitis C.
Muratori L; Bogdanos DP; Muratori P; Lenzi M; Granito A; Ma Y; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):595-603. PubMed ID: 15952102
[TBL] [Abstract][Full Text] [Related]
11. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
Béland K; Lapierre P; Marceau G; Alvarez F
J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
[TBL] [Abstract][Full Text] [Related]
12. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
Kerkar N; Ma Y; Hussain M; Muratori L; Targett C; Williams R; Bianchi FB; Mieli-Vergani G; Vergani D
J Immunol Methods; 1999 Mar; 223(2):227-35. PubMed ID: 10089101
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
[TBL] [Abstract][Full Text] [Related]
14. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
16. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
[TBL] [Abstract][Full Text] [Related]
18. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
Kirdar S; Sener AG; Cengİz M; Aydin N
APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
